Catalyst Wire Dossier Catalyst Wire Dossier

Inhaled Nitric Oxide (INO)

nitric oxide · Mallinckrodt Pharmaceuticals
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Inhaled Nitric Oxide (INO), covering 2015-08-11 to 2015-08-11. Get the full timeline:

Most recent: Clinical Trial Update: Inhaled Nitric Oxide (INO) for the Prevention of Bronchopulmonary Dysplasia (BPD) in Preterm Infants [Phase 3]

See pricing